{"id":"NCT00269113","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's Lymphoma","officialTitle":"A Randomized, Open-label Study of the Effect of MabThera Plus Chemotherapy Versus Chemotherapy Alone on Clinical Response in Patients With Indolent Non-Hodgkin's and Mantle Cell Lymphoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"1998-09","primaryCompletion":"2009-04","completion":"2009-04","firstPosted":"2005-12-23","resultsPosted":"2015-07-23","lastUpdate":"2015-07-23"},"enrollment":360,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Non-Hodgkin's Lymphoma"],"interventions":[{"type":"DRUG","name":"rituximab [MabThera/Rituxan]","otherNames":[]},{"type":"DRUG","name":"Standard chemotherapy","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"This 2 arm study will compare the efficacy and safety of the standard chemotherapy of the East German Study Group for Hematology and Oncology versus standard chemotherapy plus MabThera (375mg/m2 iv, once monthly for 8 cycles) in patients with indolent non-Hodgkin's and mantle cell lymphoma. The anticipated time on study treatment is 3-12 months, and the target sample size is 100-500 individuals.","primaryOutcome":{"measure":"Percentage of Participants Achieving CR or PR at the End of Therapy","timeFrame":"Following completion of 6 cycles (24 weeks)","effectByArm":[{"arm":"Mitoxantrone, Chlorambucil, Prednisolone (MCP)","deltaMin":75,"sd":null},{"arm":"Rituximab + MCP","deltaMin":92.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0009"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":33,"countries":["Germany"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":20,"n":177},"commonTop":["Leukopenia","Thrombocytopenia","Anaemia","Nausea","Diarrhoea"]}}